Rajesh Singh to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Rajesh Singh has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.788
-
Singh R, Gupta P, Kloecker GH, Singh S, Lillard JW. Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma. Int J Oncol. 2014 Dec; 45(6):2232-40.
Score: 0.292
-
Singh R, Stockard CR, Grizzle WE, Lillard JW, Singh S. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Int J Oncol. 2011 Aug; 39(2):373-81.
Score: 0.232
-
Clark AJ, Singh R, Leonis RL, Stahlberg EA, Clark ZS, Lillard JW. Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis and Survival Outcomes. Int J Mol Sci. 2024 Nov 18; 25(22).
Score: 0.147
-
Mir H, Kapur N, Singh R, Sonpavde G, Lillard JW, Singh S. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell Cycle. 2016; 15(6):819-26.
Score: 0.080
-
Carey KM, Young CD, Clark AJ, Dammer EB, Singh R, Lillard JW. Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment. J Ovarian Res. 2024 Dec 03; 17(1):240.
Score: 0.037